At Etiome, we envision a world where people can live healthier and longer. By building and applying detailed models of how biology shifts over the course of disease, we aim to develop Biostaged Medicines –therapies specific to disease stage, delivered to the right patient population at the right time.
Our Temporal Biodynamics™ platform applies expansive population data, single cell omics, and machine learning to accurately characterize the stages of disease progression and create targeted medicines designed to alter the course of disease. Founded by Flagship Pioneering with this vision of enabling a healthier future, Etiome is at the forefront of preemptive medicine by delivering Biostaged Medicines that halt or reverse the progression of disease across its continuum.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Cambridge, Ma, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.etiome.bio/
- HQ
- Cambridge, MA
Etiome Questions
Etiome's website is https://www.etiome.bio/
Etiome's LinkedIn profile is https://www.linkedin.com/company/etiome
Etiome has
24 employees.
View email and phone details for 24
employees at Etiome.
Etiome's industry is
Biotechnology Research
Etiome's top competitors are
Ampersand Biomedicines,
Avidicure,
Noveome Biotherapeutics, Inc.,
Stylus Medicine,
Flagship Pioneering,
City Therapeutics,
Alis Biosciences,
Merida Biosciences,
Synthetic Design Lab,
Granite Bio.
Etiome's categories are Biotechnology Research
Etiome's founding year is 2021
